The aetiology, incidence and management of type II endoleaks in standard infrarenal endovascular aortic aneurysm repair is well described. Far less data is available for thoracic stent grafting. We present a rare and interesting case of a type II endoleak post thoracic aortic stenting and highlight the aberrant anatomy that can cause this phenomenon in such cases. (Fig. 1) . Onyx (Covidien, Irvine, CA, USA) was used to perform standard coil embolization, and no flow into the aneurysm sac was found after the procedure (Fig. 2) . 
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